🇺🇸 FDA
Pipeline program

iloperidone

HSC20120137

Approved small_molecule completed

Quick answer

iloperidone for Bipolar Disorder is a Approved program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Bipolar Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials